• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者所描述的大麻使用情况。

Cannabis use as described by people with multiple sclerosis.

作者信息

Page S A, Verhoef M J, Stebbins R A, Metz L M, Levy J C

机构信息

Office of Medical Bioethics, University of Calgary, Calgary, AB, Canada.

出版信息

Can J Neurol Sci. 2003 Aug;30(3):201-5. doi: 10.1017/s0317167100002584.

DOI:10.1017/s0317167100002584
PMID:12945941
Abstract

BACKGROUND

Multiple sclerosis (MS) is one of the most common neurological diseases affecting young adults. The prevalence of MS in Alberta has been described as among the highest reported in the world, estimated at 217 per 100,000. Numerous anecdotal reports, and a few small empirical investigations have suggested that cannabis use may relieve the symptom experience of those with MS. The present study was undertaken to describe cannabis use by this patient group. Information on peoples' beliefs, practices and experiences related to use were investigated.

METHODS

A questionnaire was mailed to a sample of 780 adults with MS in southern Alberta, Canada.

RESULTS

Completed questionnaires were returned by 420/673 eligible subjects (response rate 62%). Mean sample age was 48 years and 75% were women. Respondents ranged from mildly to severely impaired. The majority of respondents (96%) was aware cannabis was potentially therapeutically useful for MS and most (72%) supported legalization for medicinal purposes. Forty-three percent had tried cannabis at some point in their lives, 16% for medicinal purposes. Symptoms reported to be ameliorated included anxiety/depression, spasticity and chronic pain. Reasons given for not trying cannabis were the fact that it is an illegal substance, concern about side effects and lack of knowledge on how to obtain it.

CONCLUSIONS

Subjective improvements in symptom experience were reported by the majority of people with MS who currently use cannabis. Further evaluation of this substance is warranted.

摘要

背景

多发性硬化症(MS)是影响年轻人的最常见神经疾病之一。据报道,艾伯塔省MS的患病率是世界上最高的之一,估计每10万人中有217人患病。众多轶事报道和一些小型实证研究表明,使用大麻可能会缓解MS患者的症状体验。本研究旨在描述该患者群体使用大麻的情况。调查了人们与使用大麻相关的信念、行为和体验信息。

方法

向加拿大艾伯塔省南部780名成年MS患者邮寄了一份问卷。

结果

673名符合条件的受试者中有420人返回了完整问卷(回复率62%)。样本平均年龄为48岁,75%为女性。受访者的损伤程度从轻度到重度不等。大多数受访者(96%)知道大麻可能对MS有治疗作用,大多数(72%)支持将其药用合法化。43%的受访者在生活中的某个时候尝试过大麻,16%是出于药用目的。据报告有所改善的症状包括焦虑/抑郁、痉挛和慢性疼痛。未尝试大麻的原因是它是一种非法物质、担心副作用以及不知道如何获取。

结论

目前使用大麻的大多数MS患者报告症状体验有主观改善。有必要对这种物质进行进一步评估。

相似文献

1
Cannabis use as described by people with multiple sclerosis.多发性硬化症患者所描述的大麻使用情况。
Can J Neurol Sci. 2003 Aug;30(3):201-5. doi: 10.1017/s0317167100002584.
2
Cannabis use in patients with multiple sclerosis.
Mult Scler. 2006 Oct;12(5):646-51. doi: 10.1177/1352458506070947.
3
Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.多发性硬化症症状缓解中大麻的使用:对美国和加拿大网络研讨会参与者的横断面调查。
Mult Scler Relat Disord. 2020 Feb;38:101516. doi: 10.1016/j.msard.2019.101516. Epub 2019 Nov 11.
4
Patterns of cannabis use among patients with multiple sclerosis.多发性硬化症患者的大麻使用模式。
Neurology. 2004 Jun 8;62(11):2098-100. doi: 10.1212/01.wnl.0000127707.07621.72.
5
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis.多发性硬化症患者对大麻的态度和使用模式。
Mult Scler Relat Disord. 2016 Nov;10:123-126. doi: 10.1016/j.msard.2016.09.008. Epub 2016 Sep 28.
6
Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.不同品种药用级大麻的治疗满意度和主观效果。
J Clin Psychopharmacol. 2014 Jun;34(3):344-9. doi: 10.1097/JCP.0000000000000129.
7
Illegal cannabis use is common among Danes with multiple sclerosis.非法使用大麻在多发性硬化症丹麦患者中很常见。
Mult Scler Relat Disord. 2019 Aug;33:5-12. doi: 10.1016/j.msard.2019.05.008. Epub 2019 May 16.
8
Effects of cannabis on cognitive function in patients with multiple sclerosis.大麻对多发性硬化症患者认知功能的影响。
Neurology. 2011 Mar 29;76(13):1153-60. doi: 10.1212/WNL.0b013e318212ab0c.
9
Limited use of medicinal cannabis but for labeled indications after legalization.药用大麻合法化后仅用于有标签的适应症,但使用受限。
Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):821-2. doi: 10.1002/pds.1152.
10
Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.基于大麻的药物——GW制药公司:高CBD、高THC、药用大麻——GW制药公司,THC与CBD比例
Drugs R D. 2003;4(5):306-9. doi: 10.2165/00126839-200304050-00005.

引用本文的文献

1
Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy.未处方大麻素与多发性硬化症:意大利伦巴第的多中心、横断面、流行病学研究。
J Neurol. 2024 Nov;271(11):7186-7205. doi: 10.1007/s00415-024-12472-4. Epub 2024 Jun 7.
2
Perceptions and engagement of patients with chronic conditions on the use of medical cannabis: a scoping review.慢性病患者对医用大麻使用的认知和参与情况:综述性研究。
Eur J Med Res. 2024 Apr 1;29(1):211. doi: 10.1186/s40001-024-01803-w.
3
The Effect of Cannabis on the Clinical and Cytokine Profiles in Patients with Multiple Sclerosis.
大麻对多发性硬化症患者临床和细胞因子谱的影响。
Mult Scler Int. 2021 Feb 5;2021:6611897. doi: 10.1155/2021/6611897. eCollection 2021.
4
Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues.大麻素受体和配体:中枢神经系统疾病的启示与新型治疗方法的探索。
Adv Exp Med Biol. 2021;1297:43-64. doi: 10.1007/978-3-030-61663-2_4.
5
Cannabis-based product use in a multiple sclerosis cohort.基于大麻的产品在多发性硬化症队列中的使用情况。
Mult Scler J Exp Transl Clin. 2019 Sep 25;5(3):2055217319869360. doi: 10.1177/2055217319869360. eCollection 2019 Jul-Sep.
6
Marijuana Use by Patients with Multiple Sclerosis.多发性硬化症患者使用大麻的情况。
Int J MS Care. 2019 Mar-Apr;21(2):57-62. doi: 10.7224/1537-2073.2017-112.
7
Medical cannabis use in Canada: vapourization and modes of delivery.加拿大医用大麻的使用:雾化与给药方式
Harm Reduct J. 2016 Oct 29;13(1):30. doi: 10.1186/s12954-016-0119-9.
8
Multiple sclerosis, cannabis, and cognition: A structural MRI study.多发性硬化症、大麻与认知:一项结构磁共振成像研究。
Neuroimage Clin. 2015 Apr 9;8:140-7. doi: 10.1016/j.nicl.2015.04.006. eCollection 2015.
9
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.关于大麻用于治疗常见国家批准的医学和精神疾病的安全性和有效性的叙述性综述。
Addict Sci Clin Pract. 2015 Apr 21;10:10. doi: 10.1186/s13722-015-0032-7.
10
Marijuana use patterns among patients with inflammatory bowel disease.炎症性肠病患者的大麻使用模式。
Inflamm Bowel Dis. 2013 Dec;19(13):2809-14. doi: 10.1097/01.MIB.0000435851.94391.37.